Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease

• Main Authors: Florian Lüke (Author), Dennis C. Harrer (Author), Karin Menhart (Author), Daniel Wolff (Author), Ernst Holler (Author), Dirk Hellwig (Author), Wolfgang Herr (Author), Matthias Grube (Author), Martin Vogelhuber (Author), Albrecht Reichle (Author), Daniel Heudobler (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Current combined intensive chemotherapy and radiation regimens yield excellent survival rates in advanced classic Hodgkin's lymphoma (cHL). However, acute toxicity in elderly, comorbid patients can be challenging and long-term survival in refractory patients remains poor.Patients...